VCNX · Vaccinex, Inc. · Executive Compensation
$1.06
At close · Dec 18
Return incl. dividend (before tax)
Going-concern doubt
— flagged Apr 15, 2025
Substantial doubt about the company's ability to continue as a going concern.
“These conditions and events raise substantial doubt about the Company’s ability to continue as a going concern. Because management’s plans have not yet been finalized and are not within the Company’s control, the implementation of such plans cannot be considered probable. As a result, the Company has concluded that management’s plans do not alleviate substantial doubt about the Company’s ability to continue as a going concern.”View the 10-K filed Apr 15, 2025
Market Cap
$2.94M
Shares
2.68M
Volume · Dec 18
94.9K
Avg daily vol (3M)
119.98K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Maurice Zauderer | President and Chief Executive Officer | $430,277 |
| Ernest S. Smith | Senior Vice President, Research and Chief Scientific Officer | $308,900 |
| Elizabeth E. Evans | Senior Vice President, Discovery and Translational Medicine, and Chief Operating Officer | $303,214 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Maurice Zauderer | President and Chief Executive Officer | $425,340 |
| Ernest S. Smith | Senior Vice President, Research and Chief Scientific Officer | $301,621 |
| Elizabeth E. Evans | Senior Vice President, Discovery and Translational Medicine, and Chief Operating Officer | $273,055 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Maurice Zauderer | President and Chief Executive Officer | $401,501 |
| Ernest S. Smith | Senior Vice President, Research and Chief Scientific Officer | $283,789 |
| Scott E. Royer | Chief Financial Officer | $253,551 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Maurice Zauderer | President and Chief Executive Officer | $444,334 |
| Ernest S. Smith | Senior Vice President, Research and Chief Scientific Officer | $283,547 |
| Scott E. Royer | Chief Financial Officer | $240,161 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Bala S. Manian | director | Resigned | 2025-03-19 |
| Chrystyna Bedrij Stecyk | director | Resigned | 2024-09-13 |
| Jill Sanchez | Interim Chief Financial Officer | Appointed | 2024-03-04 |
| Jill Sanchez | Principal Accounting Officer | Appointed | 2024-03-04 |
| Scott E. Royer | Chief Financial Officer | Retired | 2024-03-04 |
Leadership
- Maurice Zauderer CEO
- Jill Sanchez CFO, Chief Accounting Officer
- Elizabeth E. Evans COO
- Elizabeth Evans COO